Italie < Japon < Jordanie

Facettes : Author.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 31.
[20-40] [0 - 20][0 - 31]

Ident.	Authors (with country if any)	Title
001298 (2021)	Rupesh Agrawal [Singapour, Royaume-Uni] ; Ilaria Testi [Royaume-Uni] ; Cecilia S. Lee [États-Unis] ; Edmund Tsui [États-Unis] ; Marian Blazes [États-Unis] ; Jennifer E. Thorne [États-Unis] ; Annabelle A. Okada [Japon] ; Justine R. Smith [Australie] ; Peter J. Mccluskey [Australie] ; John H. Kempen [États-Unis, Éthiopie] ; Christoph Tappeiner [Suisse] ; Manisha Agarwal [Inde] ; Bahram Bodaghi [France] ; Quan Dong Nguyen [États-Unis] ; Vishali Gupta [Inde] ; Marc D. De Smet [Belgique] ; Manfred Zierhut [Allemagne] ; Carlos Pavesio [Royaume-Uni]	Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
001344 (2020)	Qianling Shi [République populaire de Chine] ; Qi Zhou [République populaire de Chine] ; Xia Wang [République populaire de Chine] ; Jing Liao [République populaire de Chine] ; Yang Yu [République populaire de Chine] ; Zijun Wang [République populaire de Chine] ; Shuya Lu [République populaire de Chine] ; Yanfang Ma [République populaire de Chine] ; Yangqin Xun [République populaire de Chine] ; Xufei Luo [République populaire de Chine] ; Weiguo Li [République populaire de Chine] ; Toshio Fukuoka [Japon] ; Hyeong Sik Ahn [Corée du Sud] ; Myeong Soo Lee [Corée du Sud] ; Zhengxiu Luo [République populaire de Chine] ; Enmei Liu [République populaire de Chine] ; Yaolong Chen [République populaire de Chine] ; Qubei Li [République populaire de Chine] ; Kehu Yang [République populaire de Chine] ; Quanlin Guan [République populaire de Chine]	Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis.
001375 (2020)	Yusuke Kuroki [Japon] ; Kazutoshi Hiyama [Japon] ; Junya Minami [Japon] ; Miyoshi Takeuchi [Japon] ; Masumi Shojima [Japon] ; Shumei Matsueda [Japon] ; Hiroshi Nagae [Japon] ; Toshiaki Nakano [Japon]	The first case of COVID-19 pneumonia in a hemodialysis patient in Japan.
001405 (2020)	Yoshinori Kadono [Japon] ; Yusaku Nakamura [Japon] ; Yoshihiko Ogawa [Japon] ; Shota Yamamoto [Japon] ; Ryuichiro Kajikawa [Japon] ; Yoshikazu Nakajima [Japon] ; Masayasu Matsumoto [Japon] ; Haruhiko Kishima [Japon]	A case of COVID-19 infection presenting with a seizure following severe brain edema.
001581 (2020)	Stephen L. Sturley [États-Unis] ; Tamayanthi Rajakumar [Nouvelle-Zélande] ; Natalie Hammond [Nouvelle-Zélande] ; Katsumi Higaki [Japon] ; Zsuzsa Márka [États-Unis] ; Szabolcs Márka [États-Unis] ; Andrew B. Munkacsi [Nouvelle-Zélande]	Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.
001583 (2020)	Tomomi Takano [Japon] ; Kumi Satoh [Japon] ; Tomoyoshi Doki [Japon] ; Taishi Tanabe [Japon] ; Tsutomu Hohdatsu [Japon]	Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
001840 (2020)	Marco Matucci-Cerinic [Italie] ; Cosimo Bruni [Italie] ; Yannick Allanore [France] ; Massimo Clementi [Italie] ; Lorenzo Dagna [Italie] ; Nemanja S. Damjanov [Serbie] ; Amato De Paulis [Italie] ; Christopher P. Denton [Royaume-Uni] ; Oliver Distler [Suisse] ; David Fox [États-Unis] ; Daniel E. Furst [Italie, États-Unis] ; Dinesh Khanna [États-Unis] ; Thomas Krieg [Allemagne] ; Masataka Kuwana [Japon] ; Eun Bong Lee [Corée du Sud] ; Mengtao Li [République populaire de Chine] ; Shiv Pillai [États-Unis] ; Yukai Wang [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Gloria Taliani [Italie]	Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
001882 (2020)	Jiancheng Zhang [République populaire de Chine] ; Bing Xie [République populaire de Chine] ; Kenji Hashimoto [Japon]	Current status of potential therapeutic candidates for the COVID-19 crisis.
001912 (2020)	Kenichiro Sato [Japon] ; Tatsuo Mano [Japon] ; Atsushi Iwata [Japon] ; Tatsushi Toda [Japon]	Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.
001978 (2020)	Stephane Picot [France] ; Aileen Marty [États-Unis] ; Anne-Lise Bienvenu [France] ; Lucille H. Blumberg [Afrique du Sud] ; Jean Dupouy-Camet [France] ; Pierre Carnevale [France] ; Shigeyuki Kano [Japon] ; Malcolm K. Jones [Australie] ; Cláudio Tadeu Daniel-Ribeiro [Brésil] ; Santiago Mas-Coma [Espagne]	Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19.
001A27 (2020)	Masashi Ohe [Japon] ; Haruki Shida [Japon] ; Satoshi Jodo [Japon] ; Yoshihiro Kusunoki [Japon] ; Masahide Seki [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon]	Macrolide treatment for COVID-19: Will this be the way forward?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffPays.i -k "Japon" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffPays.i  \
                -Sk "Japon" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Japon
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021